A Randomized, Double-Blind, Placebo-Controlled Study With an Open-Label, Long-Term Safety Phase to Evaluate the Efficacy and Safety of TV-44749 in Adults With Schizophrenia

NCT05693935 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

675

Enrollment

INDUSTRY

Sponsor class

Conditions

Schizophrenia

Interventions

DRUG: TV-44749
DRUG: Placebo

Sponsor

Teva Branded Pharmaceutical Products R&D LLC